Drug treatment and reporting.

Authors: Representative Steven Davisson

Co-authors: Representative Edward Clere

Sponsors: Senator Patricia Miller, Senator Ronald Grooms

Advisors: Representative Edward Clere, Representative Thomas Washburne, Representative Robin Shackleford


Expires standards for operation rules concerning prior authorization for a take home supply of opioid treatment medication (current law requires rules to require prior authorization for more than 14 days of medication). Prohibits an opioid treatment program from prescribing, dispensing, or providing more than a seven day supply of opioid treatment medication to a patient to take out of the facility. Requires the division of mental health and addiction (division) to establish certain standards and protocols for opioid treatment programs. Requires an opioid treatment program to follow the standards and protocols adopted by the division for each opioid treatment program patient. Requires the dispenser at an opioid treatment program to transmit certain information to the division within specified time frames. Provides that the information is subject to federal patient confidentiality regulations. Requires a provider to release certain information from a committed patient's mental health records upon request of a court. Requires that the board of pharmacy adopt a rule requiring a practitioner and a opioid treatment program to check the Indiana scheduled prescription electronic collection and tracking (INSPECT) program in specified circumstances. Requires the division to report on the information collected. Increases the penalty to a Level 6 felony for violations of the central repository for controlled substances data laws. Requires the Indiana professional licensing agency to study the impact of including all prescription drugs in the INSPECT program and sets forth requirements of the study. Requires the legislative council to assign an interim committee to study: (1) the security of the INSPECT program; and (2) whether opioid treatment programs should be prohibited from allowing patients to take home opioid treatment medication. (The introduced version of this bill was prepared by the commission on mental health and addiction.)